These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8083234)

  • 21. Ca2+ suppresses cell adhesion to osteopontin by attenuating binding affinity for integrin alpha v beta 3.
    Hu DD; Hoyer JR; Smith JW
    J Biol Chem; 1995 Apr; 270(17):9917-25. PubMed ID: 7537271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Cellular Adhesion by Immunological Targeting of Osteopontin Neoepitopes Generated through Matrix Metalloproteinase and Thrombin Cleavage.
    Jürets A; Le Bras M; Staffler G; Stein G; Leitner L; Neuhofer A; Tardelli M; Turkof E; Zeyda M; Stulnig TM
    PLoS One; 2016; 11(2):e0148333. PubMed ID: 26840958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural requirements for alpha 9 beta 1-mediated adhesion and migration to thrombin-cleaved osteopontin.
    Smith LL; Giachelli CM
    Exp Cell Res; 1998 Jul; 242(1):351-60. PubMed ID: 9665832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by alpha9beta1 integrin.
    Smith LL; Cheung HK; Ling LE; Chen J; Sheppard D; Pytela R; Giachelli CM
    J Biol Chem; 1996 Nov; 271(45):28485-91. PubMed ID: 8910476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer.
    Shojaei F; Scott N; Kang X; Lappin PB; Fitzgerald AA; Karlicek S; Simmons BH; Wu A; Lee JH; Bergqvist S; Kraynov E
    J Exp Clin Cancer Res; 2012 Mar; 31(1):26. PubMed ID: 22444159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins.
    Sung V; Stubbs JT; Fisher L; Aaron AD; Thompson EW
    J Cell Physiol; 1998 Sep; 176(3):482-94. PubMed ID: 9699501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of anti-osteopontin monoclonal antibodies: Binding sensitivity to post-translational modifications.
    Kazanecki CC; Kowalski AJ; Ding T; Rittling SR; Denhardt DT
    J Cell Biochem; 2007 Nov; 102(4):925-35. PubMed ID: 17786932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion.
    Razzouk S; Brunn JC; Qin C; Tye CE; Goldberg HA; Butler WT
    Bone; 2002 Jan; 30(1):40-7. PubMed ID: 11792563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lactadherin (formerly BA46), a membrane-associated glycoprotein expressed in human milk and breast carcinomas, promotes Arg-Gly-Asp (RGD)-dependent cell adhesion.
    Taylor MR; Couto JR; Scallan CD; Ceriani RL; Peterson JA
    DNA Cell Biol; 1997 Jul; 16(7):861-9. PubMed ID: 9260929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin.
    Yokosaki Y; Matsuura N; Sasaki T; Murakami I; Schneider H; Higashiyama S; Saitoh Y; Yamakido M; Taooka Y; Sheppard D
    J Biol Chem; 1999 Dec; 274(51):36328-34. PubMed ID: 10593924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin.
    Yokosaki Y; Tanaka K; Higashikawa F; Yamashita K; Eboshida A
    Matrix Biol; 2005 Sep; 24(6):418-27. PubMed ID: 16005200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.
    Sharp JA; Sung V; Slavin J; Thompson EW; Henderson MA
    Lab Invest; 1999 Jul; 79(7):869-77. PubMed ID: 10418827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteopontin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetradecanoylphorbol 13-acetate in mouse epidermis.
    Craig AM; Smith JH; Denhardt DT
    J Biol Chem; 1989 Jun; 264(16):9682-9. PubMed ID: 2722855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crucial role of the cryptic epitope SLAYGLR within osteopontin in renal crystal formation of mice.
    Hamamoto S; Yasui T; Okada A; Hirose M; Matsui Y; Kon S; Sakai F; Kojima Y; Hayashi Y; Tozawa K; Uede T; Kohri K
    J Bone Miner Res; 2011 Dec; 26(12):2967-77. PubMed ID: 21898593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA.
    Behrend EI; Craig AM; Wilson SM; Denhardt DT; Chambers AF
    Cancer Res; 1994 Feb; 54(3):832-7. PubMed ID: 8306346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the alpha4beta1 integrin-osteopontin interaction.
    Barry ST; Ludbrook SB; Murrison E; Horgan CM
    Exp Cell Res; 2000 Aug; 258(2):342-51. PubMed ID: 10896785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of ectokinase-mediated phosphorylation of osteopontin and bone sialoprotein by osteoblasts during bone formation in vitro.
    Zhu X; Luo C; Ferrier JM; Sodek J
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):637-43. PubMed ID: 9169595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the phosphorylated sites of metabolically 32P-labeled osteopontin from cultured chicken osteoblasts.
    Salih E; Ashkar S; Gerstenfeld LC; Glimcher MJ
    J Biol Chem; 1997 May; 272(21):13966-73. PubMed ID: 9153260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells.
    Chiang HS; Yang RS; Huang TF
    Br J Cancer; 1995 Feb; 71(2):265-70. PubMed ID: 7841039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The integrin specificity of human recombinant osteopontin.
    Caltabiano S; Hum WT; Attwell GJ; Gralnick DN; Budman LJ; Cannistraci AM; Bex FJ
    Biochem Pharmacol; 1999 Nov; 58(10):1567-78. PubMed ID: 10535747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.